omalizumab
Xolair
150 mg/mL · injection · Severe Asthma
PBS Pricing
| General patient co-payment | $25.00 |
| Concession co-payment | $7.70 |
| Full dispensed price | $848.00 |
General charges are capped at $25.00 and concession charges at $7.70, the PBS co-payments from 1 January 2026. PBS fees. The dispensed price is from the MedWatch catalogue, not a live PBS item extract.
PBS Information
- Item code
- RESx10
- Drug name
- omalizumab
- Brand name
- Xolair
- Manufacturer
- Novartis
- Formulation
- injection
- Strength
- 150 mg/mL
- Max quantity
- 2 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- Severe Asthma
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.